🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢We call on #WHO Member States and other relevant stakeholders to share good policy practices & solutions & advocate for the prioritization of #children’s needs in global, regional and national debates on access to medicines 🌍🧒🏾👧🏾 ❓What is your call? 🫱🏽‍🫲🏾Let’s join efforts to

📢Join us for our third webinar of 2024 for the GAP-f #BetterMeds4Kids webinar series on Accelerating the introduction of new paediatric products - An overview of GAP-f’s product introduction toolkit and its practical application. 📅 3 October 2024 🕑 1400 CEST register

Looking forward to seeing you all tomorrow for our webinar which launches GAP-f's product introduction toolkit. Register 👉bit.ly/4dvMYD4 to attend! PATA Elizabeth Glaser Pediatric AIDS Foundation UNICEF

📢Call for public consultation: Target product profile for paediatric formulation of Nitrofurantoin and Azithromycin 📅Deadline: 13 November Find out more 👉Call for public consultation: Target product profile for paediatric formulation of Nitrofurantoin and Azithromycin

Children of all ages are overlooked in the global #AMR response🛑 Our new policy paper details the extent of this crisis and provides recommendations to ensure children are no longer left behind. Together we can help children survive and thrive 🌍 gardp.org/publications/s…

🌍This #WorldPneumoniaDay, we must address the ongoing battle against #RSV, a leading cause of severe respiratory infections in young children👩🏾‍🍼👦🏾🧒🏾. 🧐RSV causes a potentially life-threatening disease that kills over 1⃣0⃣0⃣'0⃣0⃣0⃣ children each year, with 9⃣7⃣% of these deaths

🌍 This #WorldChildrensDay, we are proud to share the GAP-f Phase 2 Progress Report! The 📰highlights progress, challenges, and lessons learned, preparing us for GAP-f's next strategic phase. Read more here 👉 bit.ly/4exUvSl

🧒💊 19 of the 27 essential medicines for #NTDs in the WHO Essential Medicines for Children lack child-friendly formulations. 📘 Discover more in the new Paediatric R&D Landscape for Neglected Tropical Diseases report: Read 👇 bit.ly/4hXI9WA #NTDs #Bettermeds4kids

Advancing #paediatric formulations is crucial to ensure equitable, evidence-based care for #children with serious bacterial infections. The report on #WHO's technical consultation which aims to facilitate regulatory pathways to accelerate access to effective treatments is

🎉 We are excited to share our recently published meeting report from the first Paediatric Drug Optimization (PADO) meeting for childhood cancer medicines. 📑This report outlines the discussions & outcomes of the GAP-f World Health Organization (WHO)-led PADO process, a strategic approach to

📢 Save the date! Join us for our upcoming webinar on Investigating and developing better antibiotics for children: What Can We Do Now and Next? 📅 March 4, 2025 ⏰1400-1500 CET Register here 👉bit.ly/3CTjkLU

We look forward to seeing you all at the webinar today! There is still time to register 👉bit.ly/3CTjkLU 📄 Agenda 👇

📢 The Target Product Profiles for priority #paediatric formulations of azithromycin & nitrofurantoin are now available! 📄👇 🔗 bit.ly/4inEYHe Interested #Manufacturers are invited to submit an EOI for product evaluation to #WHO 🔗 Please see bit.ly/3DljnQT

📢Just published in The Lancet Child & Adolescent Health! "Simplifying medicine dosing for children by harmonising weight bands across therapeutic areas" 💊 A step toward simplifying and standardising paediatric treatment globally. 📄 Read: pubmed.ncbi.nlm.nih.gov/40113369/ #ChildHealth

📢Join us at the 78th World Health Assembly for a high-level side event on advancing access to paediatric medicines! 📅 20 May 2025, 🕰️18:30–20:30 CET at Jardin de Penthes, Geneva 🚀Let's strengthen the global ecosystem for #children's #health together! 🔗bit.ly/43TYOG9

🔍 New study reveals critical gaps in paediatric medicines on national essential medicines lists—especially in LMICs. Our children’s health is at risk. This is why our collective work is more important than ever. 🚨 It's time for equitable access to #BetterMeds4Kids. 📖 Read

📣GAP-f has just launched its 2025–2030 Strategy with a bold goal: ✅ 10 diseases ✅ 10 medicines ✅ 10 countries All by 2030. Because every child deserves timely access to the medicines they need. 📄 Learn more 👉WHO launches global accelerator for Paediatric Formulations

📢 Join us for the next #BetterMeds4Kids webinar! 🗓️ 8 July 2025 | 🕑 14:00–15:00 CEST 🌍 Topic: Optimizing tools for the prevention and treatment of RSV disease in children: Priorities and the Path Forward 📄 Featuring the launch of GAP-f’s PADO report on RSV 🔗 Register now:

Looking forward to welcoming you all to the launch today. There is still time to register here bit.ly/4kW9Hgh

📢First-Ever PADO for #RSV Report Released! Led by World Health Organization (WHO), it sets key R&D + access priorities to prevent & treat #RSV in kids over the next 3–10 yrs. Find out more👇iris.who.int/bitstream/hand… #Bettermeds4kids